Major Pharma Entity definition

Major Pharma Entity means any health care company or group of companies acting in concert for whom collective worldwide sales of ethical pharmaceutical products in the Calendar Year that preceded the Change of Control were [**] dollars ($US [**]) or more.
Sample 1Sample 2Sample 3
Major Pharma Entity means any health care company, or group of health care companies acting in concert to effect a Change of Control of Acumen, for whom the worldwide sales of pharmaceutical products (collectively in the case of such a group of companies) in the Calendar Year that preceded the Change of Control is in excess of [***], as reported by such entity or group or as reported by IMS America Ltd. of Plymouth Meeting, Pennsylvania (“IMS”) or any successor to IMS.
Sample 1Sample 2Sample 3
Major Pharma Entity means any pharmaceutical or biotechnology company (including, for purposes of this Section, its direct and indirect majority-owned subsidiaries or a group of companies acting in concert) (1) whose total market capitalization is at least $2 billion or (2) with more than $500 million in revenue related to sales of pharmaceutical products or services.
Sample 1

More Definitions of Major Pharma Entity

Major Pharma Entity means any health care company, or group of health care companies acting in concert to effect a Change of Control of DOV, for whom the worldwide sales of pharmaceutical products (collectively in the case of such a group of companies) in the Calendar Year that preceded the Change of Control is in excess of [***] U.S. Dollars ($[***]), as reported by such entity or group or as reported by IMS America Ltd. of Plymouth Meeting, Pennsylvania ("IMS") or any successor to IMS. In the event of any permitted assignment for either Party hereunder, no Patent Rights, or any Information for purposes of the definitions of DOV Know-How, MERCK Know-How and MERCK Termination Know-How, of any Third Party, or any of such Third Party's Affiliates that is an acquiring party shall be deemed "Controlled" for any purpose hereunder if such Patent Rights or Information were not so Controlled prior to such permitted assignment.
Sample 1

Related to Major Pharma Entity

  • Pfizer shall have the meaning set forth in the preamble.

  • Elan means Elan Corp and its Affiliates.

  • Major source means any stationary source (or any group of stationary sources that are located on one or more contiguous or adjacent properties, and are under common control of the same person [or persons under common control]) belonging to a single major industrial grouping and that are described in subsection (A), (B), or (C) of this definition. For the purposes of defining “major source,” a stationary source or group of stationary sources shall be considered part of a single industrial grouping if all of the pollutant emitting activities at such source or group of sources on contiguous or adjacent properties belong to the same Major Group (i.e., all have the same two-digit code) as described in the Standard Industrial Classification Manual, 1987.

  • Pro Forma Entity has the meaning given to such term in the definition of “Acquired EBITDA.”

  • Novartis shall have the meaning set forth in the Preamble.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Acquiring Party has the meaning given such term in Section 4.1.

  • Sub-Licensee means all person/ agency with whom Licensee has executed sub license agreement as per terms and conditions of license agreement executed between DMRC and the Licensee, for commercial utilization of the Bare Spaces.

  • Acquired Entity means any entity acquired by the Company or a Related Company or with which the Company or a Related Company merges or combines.

  • ABI means Anheuser-Busch InBev SA/NV, its domestic and foreign parents, predecessors, divisions, subsidiaries, affiliates, partnerships and joint ventures (excluding Crown, and, prior to the completion of the Transaction, Modelo); and all directors, officers, employees, agents, and representatives of the foregoing. The terms “parent,” “subsidiary,” “affiliate,” and “joint venture” refer to any person in which there is majority (greater than 50 percent) or total ownership or control between the company and any other person.

  • Sublicensee means a third party to whom LICENSEE grants a sublicense of certain rights granted to LICENSEE under this Agreement.

  • GSK will have the meaning set forth in the Preamble.

  • Acquired Entities means the Company and the Company Subsidiaries.

  • Co-licensed partner means a person who, with at least one other person, has the right to engage in

  • Merck has the meaning set forth in the preamble.

  • CTI means CTI Logistics Limited (ABN 69 008 778 925) and/or any Affiliate of CTI Logistics Limited as the case may be, which performs all or any of the Services.

  • Major Market means any of the United States, the United Kingdom, Japan, and any two of the following: France, Spain, Germany and Italy.

  • Acquired Entity or Business has the meaning specified in the definition of the term “Consolidated EBITDA.”

  • Transferring Party has the meaning given such term in Section 5.2(b).

  • Shire means Shire of Augusta Margaret River

  • Indigent person means a person whose household income does not exceed the minimum household income as predetermined by the council;

  • Acquired Party means the Company, any Subsidiary of the Company and any member of a Relevant Group.

  • Acquired Company means any business, corporation or other entity acquired by the Company or any Subsidiary.

  • Drug-dependent person means a person who is using a

  • Active Trade or Business means the active conduct (determined in accordance with Section 355(b) of the Code) of the business conducted by the WRECO Group members. For these purposes, members shall include only those members that are part of WRECO’s “separate affiliated group” within the meaning of Section 355(b)(3)(B) of the Code.

  • Company Subsidiary means a Subsidiary of the Company.